Elevation Oncology has won Food and Drug Administration fast-track designation for EO-3021, its lead drug candidate, in certain patients with gastrointestinal cancers.
About the SAGRES Sociedade de Titularizaçao de Créditos S.A.-Bond (PTTGU5OM0017) The SAGRES Sociedade de Titularizaçao de Créditos S.A.-Bond has a maturity date of 6/23/2039 and offers a coupon of ...